Nonalcoholic fatty liver disease
Open Access
- 1 November 2021
- journal article
- review article
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 27 (6) , 319-330
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease, affecting almost one-third of the general population and 75% of obese patients with type 2 diabetes. The aim of this article is to review the current evidence concerning the role of quercetin, a natural compound and flavonoid, and its possible therapeutic effects on this modern-day disease. Despite the fact that the exact pathophysiological mechanisms through which quercetin has a hepatoprotective effect on NAFLD are still not fully elucidated, this review clearly demonstrates that this flavonoid has potent antioxidative stress action and inhibitory effects on hepatocyte apoptosis, inflammation, and generation of reactive oxygen species, factors which are linked to the development of the disease. NAFLD is closely associated with increased dietary fat consumption, especially in Western countries. The hepatoprotective effect of quercetin against NAFLD merits serious consideration and further validation by future studies.Keywords
This publication has 108 references indexed in Scilit:
- Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic ratsBritish Journal of Pharmacology, 2013
- Quercetin in Cancer Prevention and TherapyIntegrative Cancer Therapies, 2012
- Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db miceNutrition Research and Practice, 2012
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Flavonols and cardiovascular diseaseMolecular Aspects of Medicine, 2010
- Interfering with ROS Metabolism in Cancer Cells: The Potential Role of QuercetinCancers, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Protective effects of quercetin on liver injury induced by ethanolPharmacognosy Magazine, 2010
- A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levelsAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based studyJournal of Hepatology, 2007